Lataa...
Public research funding and pharmaceutical prices: do Americans pay twice for drugs?
In the debate over prescription drug pricing, some pharmaceutical industry critics claim that U.S. taxpayers pay twice for costly therapies, because publicly supported research is a major contributor to drug discovery and American taxpayers are inadequately rewarded for their research investment due...
Tallennettuna:
| Julkaisussa: | F1000Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
F1000 Research Limited
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7642989/ https://ncbi.nlm.nih.gov/pubmed/33204410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.24934.1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|